- Home
- GOSS vs ALPS Comparison
GOSS vs ALPS Comparison
Compare GOSS & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOSS | ALPS |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.2M | 77.6M |
| IPO Year | 2018 | 2024 |
Fundamental Metrics
Financial Performance| Metric | GOSS | ALPS |
|---|---|---|
| Price | $0.17 | $0.38 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $4.19 | N/A |
| AVG Volume (30 Days) | ★ 15.5M | 64.0K |
| Earning Date | 05-07-2026 | 07-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $48,471,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $201.64 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.11 | $0.23 |
| 52 Week High | $3.87 | $1.72 |
Technical Indicators
Market Signals| Indicator | GOSS | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 50.54 | 47.86 |
| Support Level | $0.16 | $0.23 |
| Resistance Level | $0.20 | $0.43 |
| Average True Range (ATR) | 0.02 | 0.04 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 44.37 | 79.04 |
Price Performance
Historical ComparisonAbout GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
About ALPS ALPS Group Inc Ordinary Share
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.